Xueling Li

2.1k citations
47 papers · 1.6k indexed · 1 hit paper · h-index 18
Topics
Chronic Kidney Disease and Diabetes (4 papers)Renal Diseases and Glomerulopathies (3 papers)Innovation and Knowledge Management (3 papers)

In The Last Decade

Xueling Li

43 papers receiving 1.6k citations

Hit Papers

Mesenchymal stromal cell-derived exosomes attenuate myoca...20192026202120232019100200300400500

Peers

Xueling Li
Comparison fields: 5 of 128
  • Molecular Biology 848
  • Cancer Research 339
  • Cardiology and Cardiovascular Medicine 249
  • Surgery 228
  • Endocrinology, Diabetes and Metabolism 138
Replace Chi Zhang with:
Chi Zhang China
Hongmei Tan China
Abdelali Agouni Qatar
Tao-Cheng Wu Taiwan
Ying Cheng China
Song Xue China
Yuki Izawa‐Ishizawa Japan
Steven T. Haller United States
Shaokang Pan China
Xueling Li relative to Chi Zhang China Chi Zhang's profile →
Citations per field
00.5×1.5×
Chi Zhang · 1×
Citations per year

Countries citing papers authored by Xueling Li

Since Specialization
Citations

This map shows the geographic impact of Xueling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueling Li more than expected).

Fields of papers citing papers by Xueling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueling Li. The network helps show where Xueling Li may publish in the future.

Co-authorship network of co-authors of Xueling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xueling Li. A scholar is included among the top collaborators of Xueling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueling Li. Xueling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 5
5 4
6 3
7 7
8 4
9 14
10 1
11 0
12 47
13 11
14 8
15 123
16 34
17 39
18 48
19 42
20 26

About Xueling Li

Xueling Li is a scholar working on Nephrology, Clinical Biochemistry and Management of Technology and Innovation, having authored 47 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Innovation and Knowledge Management (3 papers). The work is most often cited by research in Cancer Research (339 citations), Nephrology (126 citations) and Molecular Biology (848 citations). Xueling Li has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Jinxuan Zhao, Biao Xu, Fu Chen, Jun Xie, Jiaxin Hu, Xuan Sun, Shuaihua Qiao, Ling Gao, Yifei Zhong and Jin Geng. Their work appears in journals such as Nature Communications, Environmental Science & Technology and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026